| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999662 | Urologic Oncology: Seminars and Original Investigations | 2015 | 8 Pages |
Abstract
These results indicate an intimate relationship between MMP9 overexpression and VM formation in RCC. Treatments targeting VM formation by inhibiting the activity of MMP9 could be beneficial in RCC therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hao M.D., Jin-cheng M.D., Ph.D., Fa-ming M.D., Bin M.D., Ph.D., Xu M.D., Ph.D., Jin-tao M.D., Ph.D., Hua M.D., Cheng-qiang M.D., Dao-hu M.D., Ph.D., Shao-peng M.D., Ph.D.,